11:30 AM EST - Bausch + Lomb Corporation : Today announced the publication of new research on real world experience with enVista Aspire and enVista Aspire toric intraocular lenses (IOLs). The study, published in the journal Ophthalmology and Therapy, found that these enhanced monofocal lenses delivered both good distance and functional intermediate vision, thus meeting the needs of many cataract patients. Bausch + Lomb Corporation
shares T.BLCO are trading up $0.46 at $25.36.
